Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 78, Issue 3, Pages 311-338
Publisher
Springer Science and Business Media LLC
Online
2021-10-27
DOI
10.1007/s00228-021-03216-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intranasal esketamine: From origins to future implications in treatment-resistant depression
- (2021) Benjamin Sanders et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies
- (2020) Wei Zheng et al. JOURNAL OF AFFECTIVE DISORDERS
- A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019
- (2020) Walter S. Marcantoni et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective
- (2019) Álvaro López-Díaz et al. BRITISH JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials
- (2019) Katrina Witt et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- The effectiveness and safety of acupuncture for depression: An overview of meta-analyses
- (2019) Meixuan Li et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
- (2018) Somaye Arabzadeh et al. JOURNAL OF AFFECTIVE DISORDERS
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
- (2018) Andrea Cipriani et al. LANCET
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
- (2018) Yoav Domany et al. BRITISH JOURNAL OF PSYCHIATRY
- Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion
- (2018) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- Repeat-Dose Ketamine Augmentation for Treatment-Resistant Depression with Chronic Suicidal Ideation: A Randomized, Double Blind, Placebo Controlled Trial
- (2018) Dawn F. Ionescu et al. JOURNAL OF AFFECTIVE DISORDERS
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders
- (2017) Samuel T. Wilkinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities
- (2017) S. E. Strasburger et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Methodological quality of systematic reviews on treatments for depression: a cross-sectional study
- (2017) V. C. H. Chung et al. Epidemiology and Psychiatric Sciences
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Instruments for the assessment of suicide risk: A systematic review evaluating the certainty of the evidence
- (2017) Bo Runeson et al. PLoS One
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
- (2016) Morteza Jafarinia et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis
- (2015) Ellen E. Lee et al. GENERAL HOSPITAL PSYCHIATRY
- Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
- (2015) Ying Xu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
- (2015) Paul E. Greenberg et al. JOURNAL OF CLINICAL PSYCHIATRY
- Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
- (2015) Y.-D. Hu et al. PSYCHOLOGICAL MEDICINE
- PATHOPHYSIOLOGY OF DEPRESSION: DO WE HAVE ANY SOLID EVIDENCE OF INTEREST TO CLINICIANS?
- (2015) GREGOR HASLER World Psychiatry
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Pilot dose–response trial of i.v. ketamine in treatment-resistant depression
- (2014) Rosalyn Lai et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ghost- and Guest-Authored Pharmaceutical Industry–Sponsored Studies: Abuse of Academic Integrity, the Peer Review System, and Public Trust
- (2013) Dennis K Flaherty ANNALS OF PHARMACOTHERAPY
- Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
- (2013) Brenda WJH Penninx et al. BMC Medicine
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
- (2011) Gerald W. Valentine et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Rapid Onset of Antidepressant Action
- (2009) Rodrigo Machado-Vieira et al. JOURNAL OF CLINICAL PSYCHIATRY
- Impugning the Integrity of Medical Science
- (2008) Catherine D. DeAngelis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More